Skip to content
★ Sign in to follow
MD
Total declarations
19
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€298k

Latest filing published 04 Jun 2019 for BIOGEN INC..

Filing timeline

BuySale
Michael D. Ehlers

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

Michael D. Ehlers: trading record in brief

Michael D. Ehlers appears in our data through filings on Biogen Inc. shares, published by SEC (Form 4). We count 19 filings; the first trade dates from 1 June 2016 and the latest from 1 June 2019.

The open-market record consists of 1 sale worth €298k, with no purchase. Besides market trades, the filings include 11 share grants and 7 option exercises.

Most recently, on 4 June 2019, the filings show a share grant worth €99k in Biogen Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Michael D. Ehlers

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations19 total
  • ◇
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    0SEC
    1,126 shares0Common StockSEC:0001127602-19-020742:1
  • ◆
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    100,873 USD12SEC
    460 shares@ US$219.296.8% of flowCommon StockSEC:0001127602-19-020742:0
  • ◆
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    109,645 USD12SEC
    500 shares@ US$219.297.4% of flowCommon StockSEC:0001127602-19-020742:2
  • ◆
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    249,320 USD13SEC
    749 shares@ US$332.8715.1% of flowCommon StockSEC:0001127602-19-007251:1
  • ◇
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    0SEC
    1,685 shares0Common StockSEC:0001127602-19-007251:0
  • ◆
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    254,905 USD13SEC
    798 shares@ US$319.4315.5% of flowCommon StockSEC:0001127602-19-006077:3
  • ◆
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    149,813 USD12SEC
    469 shares@ US$319.439.1% of flowCommon StockSEC:0001127602-19-006077:1
  • ◇
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    0SEC
    1,578 shares0Common StockSEC:0001127602-19-006077:0
  • ◇
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    0SEC
    2,249 shares0Common StockSEC:0001127602-19-006077:2
  • ▼
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    350,000 USD13SEC
    1,000 shares@ US$350.0020.4% of flowCommon StockSEC:0001127602-18-028453:0
  • ◇
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    0SEC
    1,384 shares0Common StockSEC:0001127602-18-020025:1
  • ◆
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    136,661 USD12SEC
    460 shares@ US$297.097.2% of flowCommon StockSEC:0001127602-18-020025:0
  • ◆
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    183,007 USD12SEC
    616 shares@ US$297.099.6% of flowCommon StockSEC:0001127602-18-020025:2
  • ◇
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    0SEC
    1,712 shares0Common StockSEC:0001127602-18-007195:0
  • ◆
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    152,384 USD12SEC
    509 shares@ US$299.387.5% of flowCommon StockSEC:0001127602-18-007195:1
  • ◆
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    84,800 USD11SEC
    336 shares@ US$252.384.6% of flowCommon StockSEC:0001127602-17-020555:0
  • ◆
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    103,728 USD12SEC
    411 shares@ US$252.385.7% of flowCommon StockSEC:0001127602-17-020555:2
  • ◇
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    0SEC
    1,259 shares0Common StockSEC:0001127602-17-020555:1
  • ◆
    EVP, Research and DevelopmentExecutivesBiogen Inc.
    0SEC
    3,034 shares0Common StockSEC:0001127602-16-054487:0

19 of 19 declarations